Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma

被引:154
作者
Nies, AT
König, J
Pfannschmidt, M
Klar, E
Hofmann, WJ
Keppler, D
机构
[1] Deutsch Krebsforschungszentrum, Div Tumor Biochem, D-69120 Heidelberg, Germany
[2] Univ Heidelberg, Dept Pathol, D-6900 Heidelberg, Germany
[3] Univ Heidelberg, Dept Surg, D-6900 Heidelberg, Germany
关键词
multidrug resistance; multidrug resistance protein 2/3; ATP-dependent transporter; immunolocalization; hepatocellular carcinoma;
D O I
10.1002/ijc.1498
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Treatment of hepatocellular carcinoma (HCC) by chemotherapy is often impeded by the intrinsic multidrug resistance (MDR) of this frequent primary cancer of the liver. The MDR phenotype can be caused by ATP-dependent export of chemotherapeutic drugs across the plasma membrane being mediated by transporters of the MDR P-glycoprotein family or of the multidrug resistance protein (MRP) family. To elucidate the role of MRP family members in HCC, we analyzed the expression and subcellular localization of MRP I (ABCC1) MRP2 (ABCC2) and MRP3 (ABCC3); all 3 isoforms have been shown to confer resistance to chemotherapeutic drugs. Semiquantitative RT-PCR demonstrated that MRP2 and MRP3 mRNA expression in HCC was at least 10-fold higher than MRP1 mRNA expression. MRP2 immunostaining was observed in 87% (33/38) of HCC samples. MRP2 was localized in the plasma membrane in a polarized fashion, either in trabecular structures resembling the canalicular membrane or in the luminal membrane when cells had a pseudoglandular arrangement. MRP3 was detected in all samples examined (9/9) by RT-PCR and by immunofluorescence microscopy. MRP3 was localized to the basolateral membrane of carcinoma cells. Double-label immunofluorescence microscopy with antibodies specific for MRP2 or MRP3 indicated that carcinoma cells expressed both MRP isoforms simultaneously. When MRP I was detected by immunofluorescence microscopy, it was localized on the intracellular membranes of carcinoma cells. Thus, plasma membrane expression of MRP2 and MRP3, but not of MRP1, can contribute to the MDR phenotype of HCC. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:492 / 499
页数:8
相关论文
共 44 条
  • [1] Biochemical, cellular, and pharmacological aspects of the multidrug transporter
    Ambudkar, SV
    Dey, S
    Hrycyna, CA
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 361 - 398
  • [2] Human mast cells secreting leukotriene C4 express the MRP1 gene-encoded conjugate export pump
    Bartosz, G
    König, J
    Keppler, D
    Hagmann, W
    [J]. BIOLOGICAL CHEMISTRY, 1998, 379 (8-9) : 1121 - 1126
  • [3] A family of drug transporters: The multidrug resistance-associated proteins
    Borst, P
    Evers, R
    Kool, M
    Wijnholds, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16): : 1295 - 1302
  • [4] Bruix J, 1997, HEPATOLOGY, V25, P259
  • [5] Buchler M, 1996, J BIOL CHEM, V271, P15091
  • [6] Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter
    Chen, ZS
    Kawabe, T
    Ono, M
    Aoki, S
    Sumizawa, T
    Furukawa, T
    Uchiumi, T
    Wada, M
    Kuwano, M
    Akiyama, S
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (06) : 1219 - 1228
  • [7] OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE
    COLE, SPC
    BHARDWAJ, G
    GERLACH, JH
    MACKIE, JE
    GRANT, CE
    ALMQUIST, KC
    STEWART, AJ
    KURZ, EU
    DUNCAN, AMV
    DEELEY, RG
    [J]. SCIENCE, 1992, 258 (5088) : 1650 - 1654
  • [8] Cui YH, 1999, MOL PHARMACOL, V55, P929
  • [9] EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
  • [10] 2-E